Track market-moving stories before they get noisy

The leading edge of 70 million baby boomers just started turning 80, and new senior housing construction sits at record lows. Three REITs are positioned to capture that collision, each through a structure that carries very different risk and income…

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.

Senior housing and skilled nursing sit at the front end of a demographic wave that income investors near retirement are watching from personal experience: the leading edge of the nearly 70 million baby boomers has just begun turning 80 this year, while new construction starts remain at record lows. Ventas management framed the setup bluntly on its latest call: “there were a little over a thousand starts this quarter and there’s two million people turning 80 just in 2026 and that demographic demand wave continues for a decade.” All three names below are equity REITs (not mortgage REITs), and each captures the tailwind through a different structure.

Welltower: Scale Leader With SHOP Firing on All Cylinders Welltower (NYSE:WELL | WELL Price Prediction) is the largest senior housing landlord in the group, with a market cap of approximately $173.7 billion as of September 3, 2026. The portfolio spans Seniors Housing Operating (SHOP), Seniors Housing Triple-net, Outpatient Medical, and Long-Term/Post-Acute Care properties across the US, UK, and Canada. The SHOP structure matters for income investors: Welltower participates directly in facility operating results, not just rent collection, so occupancy and rate growth flow through to cash flow.

Q2 2026 was a record quarter. Normalized FFO came in at $1.60 per diluted share versus $0.65 consensus, revenue rose 40.9% YoY to $3.54 billion, SHOP same-store NOI grew 20.5% YoY, and SHOP same-store occupancy reached 89.4% (up from 86.1% YoY) with RevPOR growth of 5.2%. Management noted the 15th consecutive quarter in which NOI growth exceeded 20%, with operating margin expanding 300 basis points to over 32%, surpassing pre-COVID levels.

The quarterly dividend was raised to $0.85 per share (declared July 27, 2026, paid August 20, 2026), producing an annualized forward dividend of $3.40. Shares closed at $241.12 on September 3, 2026. Full-year 2026 Normalized FFO guidance was raised to $6.36 to $6.44 per diluted share. Measured on the right metric for REITs, FFO covers the $3.40 annualized dividend comfortably.

Bull case: Welltower is compounding cash flow off a scarce, needs-based asset class with pricing power. Approximately 96% of transactions were described as off-market, and management is layering in newer-vintage acquisitions at roughly 75% in-place occupancy at a circa 20% discount to replacement cost, leaving embedded lease-up upside.

One risk: Shares are up 31.27% year-to-date and 46.08% over the past year, so any operator hiccup, integration stumble on the C$4.1 billion Amica Senior Lifestyles acquisition, or FX turbulence in the UK/Canada books could compress the premium fast.

Ventas: SHOP Pivot With a Multi-Year Runway Ventas (NYSE:VTR) is a healthcare REIT focused on senior housing operating portfolio (SHOP), Outpatient Medical & Research (OM&R), and triple-net leased properties, with a market cap of approximately $47.2 billion as of September 3, 2026. Like Welltower, Ventas has been aggressively shifting its mix toward SHOP, where operator economics flow through directly. Management said on the Q2 call, “we are building shop to be 60% of our portfolio by the end of this year on a $60 billion enterprise.”

Q2 2026 delivered the fifth consecutive quarter beating analyst expectations. Normalized FFO reached $0.97 per share, up 9% YoY; SHOP Same-Store Cash NOI grew 16.3% YoY (US SHOP 18%); average occupancy rose 300 bps YoY (US SHOP 360 bps); RevPOR growth was 5%; and total company Same-Store Cash NOI grew 10.3%. The balance sheet firmed up too: Net Debt-to-Further Adjusted EBITDA improved to 4.7x from 5.6x YoY.

The quarterly dividend is $0.52 per share, with an annualized forward dividend of $2.08. Shares closed at $92.11 on September 3, 2026. Full-year 2026 Normalized FFO guidance was raised to $3.85 to $3.90 per share (8% to 10% YoY growth). Coverage on FFO, again the right metric here, is comfortable.

Bull case: CEO Debra Cafaro’s framing lays it out plainly: “Demographic demand is strong and getting stronger as the baby boomers begin turning 80 this year. Meanwhile, new supply remains at historic lows, setting up a compelling multiyear runway for growth and value creation.” Ventas has completed over $8 billion in investments since the beginning of 2024, adding more than 23,000 units across 174 communities to its SHOP portfolio, and its 2026 investment target was raised to $4.5 billion (from $3 billion), focused on senior housing.

One risk: The growth is being partly funded with equity. Ventas settled 31.4 million shares via forward sales for $2.6 billion year-to-date, and management said equitizing senior housing investments “I would expect that to continue.” Continued issuance can dilute per-share growth if deals underperform underwriting.

Omega Healthcare Investors: Skilled Nursing Cash Flow With a Coverage Lift Omega Healthcare Investors (NYSE:OHI) is the outlier of the three: a skilled nursing and senior housing REIT, primarily triple-net leased, expanding into RIDEA operating structures and international (UK/Canada), with a market cap of approximately $14.3 billion as of September 3, 2026. Triple-net means Omega collects contractual rent while operators bear staffing and expense volatility, a very different income profile from Welltower’s and Ventas’s SHOP-heavy books. That structure caps upside in an operator boom but insulates cash flow from labor-cost spikes.

AFFO was $0.83 per diluted share (up from $0.77 YoY); FAD per share was $0.78, up 5.4% YoY; revenue rose 16.2% YoY to $328.25 million; trailing 12-month EBITDAR coverage improved to 1.65x (from 1.55x YoY); and operator occupancy was stable at 82.6%. Omega executed a strategic sale of 18 CommuniCare facilities in MD and WV for $479.9 million gross proceeds, and transitioned the underperforming Laurels portfolio to stronger operators. On the call, Vikas Gupta said, “We really have no major concerns in our portfolios this time.”

The quarterly dividend was raised by a penny to $0.68 per share (declared July 23, 2026, paid August 14, 2026), producing an annualized forward dividend of $2.72. Shares closed at $47.04 on September 3, 2026. Full-year 2026 AFFO guidance was raised to $3.22 to $3.26 per diluted share, midpoint $3.24. Measured against AFFO (the appropriate coverage metric here), the $2.72 annualized dividend is covered.

Bull case: The skilled nursing operating backdrop is finally healing. CEO Taylor Pickett called it “the most favorable operating backdrop that I have known in my career,” and Megan Krull noted that “In June 2026, four years later, according to the Bureau of Labor Statistics, the industry finally recovered to those prior levels” after a 14% pandemic-era workforce loss. Combined with rising coverage and disciplined portfolio pruning, the setup supports the dividend.

One risk: Operator concentration and government reimbursement. Genesis Healthcare remains in Chapter 11 bankruptcy with $148.5 million in loans outstanding, and skilled nursing is heavily tied to Medicaid and Medicare. CMS set the 2026 skilled nursing facility daily coinsurance for days 21 through 100 at $217.00, up from $209.50 in 2025, a modest tailwind, but state Medicaid budgets remain the swing factor. Layer on the announced retirement of CEO Taylor Pickett after 25 years leading Omega, and there is transition risk to watch.

Bottom Line The three REITs offer distinct ways to own the same demographic wave. Welltower is the scale operator capturing the affluent-boomer trade with SHOP economics and margin leverage. Ventas is the pivot story, converting a healthcare REIT into a senior-housing-heavy growth vehicle. Omega is the yield play, taking triple-net rent from a healing skilled nursing industry with improving coverage and a covered payout. Income investors near retirement can build the exposure to fit the risk they want, from operating leverage at Welltower to contractual rent at Omega (the whole idea of living off the checks without touching the shares is the subject of our free dividend ladder guide, here), and the demand runway behind all three extends well into the next decade.

Contact [email protected] for any questions or corrections.

Why Welltower's Growth Story Might Outrun Its Rich ValuationVentas NYSE: VTR raised its 2026 investment and earnings outlook after reporting second-quarter growth led by its senior housing operating portfolio, or SHOP, as occupancy gains and rent growth lifted property-level results.

Chairman and Chief Executive Officer Debra A. Cafaro said the company generated 10% total-company same-property net operating income, or NOI, growth in the quarter. U.S. SHOP NOI rose 18% year over year, accompanied by 360 basis points of occupancy growth, she said. Normalized funds from operations, or FFO, increased 9% from a year earlier to $0.97 per share.

Get Ventas alerts:

6 largest healthcare REITs to buy and how to invest The company increased its full-year normalized FFO guidance to a range of $3.85 to $3.90 per share, representing projected growth of 8% to 10%. Ventas also lifted its expected 2026 investment volume to $4.5 billion from $3 billion, primarily focused on senior housing.

Senior Housing Drives Operating Results Executive Vice President, Senior Housing and Chief Investment Officer Justin Hutchens said same-store SHOP NOI increased 16% year over year during the second quarter, with the U.S. portfolio contributing 18% growth. Same-store average occupancy rose 300 basis points across the portfolio and 360 basis points in the U.S.

Analysts See Strong Upside Trade for Undervalued REITsWithin NIC’s top 99 markets, Ventas’ same-store communities outperformed industry occupancy averages by about 150 basis points, according to Hutchens. Revenue per occupied room, or RevPOR, increased 5%, reflecting both in-place rent increases and higher move-in rents.

Same-store revenue grew nearly 9%, while operating expenses increased 5%. That combination expanded NOI margins by 210 basis points to 31%, while incremental margin flow-through reached 55%.

Hutchens said the company’s U.S. senior housing portfolio is 87% occupied, while its non-same-store portfolio is 83% occupied. The non-same-store group represents about 25% of SHOP NOI and includes acquisitions, transitions and redevelopment projects.

Ventas is maintaining its same-store SHOP NOI growth outlook of 16% at the midpoint. The company raised its full-year occupancy-growth target to 300 basis points from 270 basis points after a strong start to the year, and management said the May-through-September key selling season was tracking in line with its expectations.

Hutchens highlighted performance at more highly occupied communities as evidence of further opportunity. The approximately half of U.S. same-store communities that were at least 90% occupied posted 25% NOI growth and 6% RevPOR growth. About 10% of the company’s SHOP communities were at or near full occupancy, and those U.S. properties were producing about 7% RevPOR growth and roughly 20% NOI growth, he said.

Investment Outlook Raised to $4.5 Billion Ventas completed more than $3 billion of senior housing-focused investments across 27 transactions year to date, Hutchens said. The investments were underwritten to double-digit to mid-teens unlevered internal rates of return, had an average expected first-year yield of 6.6%, and were acquired at an average price of $358,000 per unit.

The company expects to complete approximately another $1 billion of investments under contract, with that group expected to produce yields and returns similar to its completed investments. About two-thirds of that pending activity is value-add product with a higher growth profile, Hutchens said.

More than 90% of year-to-date investments were relationship-driven, including off-market transactions and transactions involving repeat sellers or existing operating partners. Hutchens said Ventas’ underwriting and data capabilities have helped the company close transactions in about two months from start to finish.

Cafaro said Ventas has completed more than $8 billion of investments since the beginning of 2024, adding more than 23,000 units across 174 communities to its SHOP portfolio. The company expects SHOP to represent 60% of its $60 billion enterprise by the end of 2026.

Management said demographic demand and limited new supply continue to support its senior housing strategy. Cafaro said the leading edge of the nearly 70 million baby boomers began turning 80 in 2026, while new senior housing construction starts remain at record lows.

On development, Hutchens said Ventas is primarily focused on acquiring in-place cash flows rather than developing new properties. He said current rents would generally need to be at least 25% higher for projects to generate the roughly 8% development yield that developers may seek, though luxury projects in select markets could be exceptions.

Balance Sheet Strength and Capital Recycling Chief Financial Officer Robert Probst said net debt to EBITDA improved to 4.7 times at the end of the second quarter, the company’s lowest leverage level in more than a decade. That was a 90-basis-point improvement from a year earlier and a 30-basis-point sequential improvement.

Ventas completed $3.4 billion of investments year to date and raised $4.2 billion of equity, including $1.6 billion that remained unsettled at quarter-end. Liquidity totaled $4.9 billion.

The updated normalized FFO guidance midpoint of $3.88 per share is $0.02 above the prior midpoint. Probst said higher senior housing investment activity, net of additional capital recycling, contributed $0.03 per share to the improvement. That was partly offset by $0.01 per share from higher interest rates and a higher share price.

The company increased its disposition and loan repayment assumptions to $700 million, with sales expected to focus on non-SHOP and non-strategic assets. Probst characterized the disposition activity as portfolio “hygiene” intended to improve the company’s growth rate. Management said approximately $100 million of anticipated loan repayments carry an 11% yield.

Other Portfolio Performance Ventas’ outpatient medical and research portfolio, known as OMAR, generated 5% same-store cash NOI growth in the second quarter. After adjusting for cash fee income, outpatient medical same-store cash NOI growth was 3%, supported by a 50-basis-point occupancy improvement and 88% tenant retention.

The triple-net portfolio generated 3% same-store cash NOI growth, and Probst said the company expects the portfolio’s year-over-year NOI growth rate to increase in the second half.

In the research portfolio, Hutchens said several tenants did not renew leases, producing an expected year-over-year NOI impact of about $900,000. He said the second-quarter run rate in research is expected to reflect the remainder of the year.

About Ventas (NYSE:VTR)Ventas, Inc NYSE: VTR is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas' business model combines property ownership with active asset management and capital markets activity.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to [email protected].

Should You Invest $1,000 in Ventas Right Now?Before you consider Ventas, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ventas wasn't on the list.

While Ventas currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Posted by Defense World Staff on Jul 27th, 2026

Ventas (NYSE:VTR – Get Free Report) is projected to post its Q2 2026 results after the market closes on Wednesday, July 29th. Analysts expect Ventas to post earnings of $0.1423 per share and revenue of $1.6808 billion for the quarter. Investors may visit the the company’s upcoming Q2 2026 earning report page for the latest details on the call scheduled for Thursday, July 30, 2026 at 10:00 AM ET.

Ventas (NYSE:VTR – Get Free Report) last issued its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing analysts’ consensus estimates of $0.12 by ($0.01). Ventas had a return on equity of 2.09% and a net margin of 4.25%.The business had revenue of $1.65 billion for the quarter, compared to analysts’ expectations of $1.59 billion. During the same period last year, the business earned $0.84 earnings per share. The company’s revenue for the quarter was up 22.0% on a year-over-year basis. On average, analysts expect Ventas to post $4 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Ventas Trading Up 0.1% Shares of Ventas stock opened at $100.61 on Monday. Ventas has a 1 year low of $65.15 and a 1 year high of $100.84. The company has a debt-to-equity ratio of 0.95, a current ratio of 0.25 and a quick ratio of 0.25. The business has a 50 day moving average price of $88.17 and a 200 day moving average price of $84.91. The company has a market capitalization of $48.92 billion, a P/E ratio of 182.94, a P/E/G ratio of 2.16 and a beta of 0.70.

Ventas Dividend Announcement The business also recently declared a quarterly dividend, which was paid on Thursday, July 16th. Shareholders of record on Tuesday, June 30th were given a dividend of $0.52 per share. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $2.08 annualized dividend and a yield of 2.1%. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insider Buying and Selling at Ventas In other Ventas news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction on Thursday, May 14th. The stock was sold at an average price of $90.20, for a total value of $103,910.40. Following the completion of the transaction, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler purchased 2,500 shares of Ventas stock in a transaction on Wednesday, June 3rd. The shares were acquired at an average cost of $78.81 per share, for a total transaction of $197,025.00. Following the purchase, the director owned 19,202 shares in the company, valued at approximately $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Insiders own 0.53% of the company’s stock.

Hedge Funds Weigh In On Ventas Large investors have recently added to or reduced their stakes in the business. State Street Corp boosted its stake in Ventas by 2.5% in the 4th quarter. State Street Corp now owns 29,662,635 shares of the real estate investment trust’s stock worth $2,309,234,000 after buying an additional 735,620 shares during the last quarter. Price T Rowe Associates Inc. MD increased its stake in shares of Ventas by 27.9% during the 4th quarter. Price T Rowe Associates Inc. MD now owns 9,176,254 shares of the real estate investment trust’s stock valued at $710,060,000 after acquiring an additional 2,000,341 shares during the last quarter. Dimensional Fund Advisors LP increased its stake in shares of Ventas by 5.1% during the 4th quarter. Dimensional Fund Advisors LP now owns 6,937,575 shares of the real estate investment trust’s stock valued at $536,853,000 after acquiring an additional 336,432 shares during the last quarter. Northern Trust Corp lifted its holdings in shares of Ventas by 1.7% during the 3rd quarter. Northern Trust Corp now owns 6,402,941 shares of the real estate investment trust’s stock worth $448,142,000 after acquiring an additional 108,990 shares during the period. Finally, Morgan Stanley lifted its holdings in shares of Ventas by 19.9% during the 4th quarter. Morgan Stanley now owns 6,344,347 shares of the real estate investment trust’s stock worth $490,926,000 after acquiring an additional 1,051,836 shares during the period. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades A number of equities analysts have recently weighed in on the company. Evercore reissued an “outperform” rating and issued a $95.00 price target on shares of Ventas in a report on Wednesday, April 29th. Royal Bank Of Canada increased their price objective on Ventas from $91.00 to $98.00 and gave the company an “outperform” rating in a research note on Monday, May 4th. Jefferies Financial Group lifted their price objective on Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research report on Tuesday, May 12th. BMO Capital Markets reissued an “outperform” rating and issued a $100.00 target price on shares of Ventas in a research note on Monday, May 4th. Finally, Citigroup upped their target price on shares of Ventas from $96.00 to $100.00 and gave the company a “buy” rating in a report on Friday, May 1st. Fifteen analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $96.50.

Read Our Latest Research Report on Ventas

About Ventas (Get Free Report)

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.

Recommended Stories Five stocks we like better than Ventas RTX and Lockheed Earnings: Can Strong Guidance Reset the Defense Trade? These 4 Earnings Reports Expose the Market’s Growing Economic Divide Broadcom May Be the Biggest Winner From Alphabet’s Earnings Volatility Is Back and These 3 Market Tollbooths Are Best Positioned to Profit

Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.

« PREVIOUS HEADLINEAllspring Global Investments Holdings LLC Lowers Holdings in Workday, Inc. $WDAY

NEXT HEADLINE »Dimensional Fund Advisors LP Boosts Stock Position in Veralto Corporation $VLTO